Analysis of Costs and Trends of Antibiotic Consumption at the National Hospital of Obstetrics and Gynecology (NHOG) in 2019-2023

Objective: Analyzing the cost and consumption of antibiotics at National hospital of Obsteric and Gynecogoly from 2019 to 2023.Subjects and methods: A cross-sectional descriptive study based on data on antibiotics used in inpatient treatment at the National hospital of Obsteric and Gynecogoly from 01/01/2019 to 31/12/2023, using cost analysis and DDD analysis methods.Results: The beta-lactam group accounted for the majority of consumption value (93.7%). Intravenous antibiotics accounted for 91.4% in value. The proportion of original and generic brand-name drug use values was 57.4% and 42.6%. The Department of Obstetric Pathology and department of Obstetric Infections were two departments that used the most antibiotics. The average total DDD/100 bed days of the hospital was 66.2; in which the penicillin and cephalosporin groups had the highest DDD/100 bed days. Antibiotics that need to be managed according to Decision 5631/QD-BYT account for a low proportion of consumption, while meropenem antibiotics tend to increase in consumption (p<0.05).Conclusion: The study shows an overall picture of the situation of antibiotic use at National hospital of Obsteric and Gynecogoly in the 5-year period from 2019 to 2023. It is the basis for proposing that the Drug Treatment Council implement a comprehensive antibiotic management program.